These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 14960388)
1. Oligonucleotides make sensible strides. Doran G Drug Discov Today; 2004 Feb; 9(3):114-6. PubMed ID: 14960388 [No Abstract] [Full Text] [Related]
2. Development of siRNA for therapeutics: efficient synthesis of phosphorothioate RNA utilizing phenylacetyl disulfide (PADS). Ravikumar VT; Andrade M; Carty RL; Dan A; Barone S Bioorg Med Chem Lett; 2006 May; 16(9):2513-7. PubMed ID: 16481168 [TBL] [Abstract][Full Text] [Related]
9. Applications of antisense and siRNAs during preclinical drug development. Thompson JD Drug Discov Today; 2002 Sep; 7(17):912-7. PubMed ID: 12546934 [TBL] [Abstract][Full Text] [Related]
10. Application of modified antisense oligonucleotides and siRNAs as antiviral drugs. Wagner A; Bock CT; Fechner H; Kurreck J Future Med Chem; 2015; 7(13):1637-42. PubMed ID: 26381598 [No Abstract] [Full Text] [Related]
11. The long march of antisense. Jones D Nat Rev Drug Discov; 2011 Jun; 10(6):401-2. PubMed ID: 21629279 [No Abstract] [Full Text] [Related]
12. Making dollars and sense of antisense. Wiggins P Expert Opin Investig Drugs; 2005 Feb; 14(2):111-5. PubMed ID: 15757390 [No Abstract] [Full Text] [Related]
13. Antisense applications for biological control. Pan WH; Clawson GA J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307 [TBL] [Abstract][Full Text] [Related]
14. Making sense of antisense and interference. Morrow T Manag Care; 2003 Nov; 12(11):62-3. PubMed ID: 14666589 [No Abstract] [Full Text] [Related]
15. What's Next for Gastrointestinal Disorders: No Needles? Urbanska AM; Karagiannis ED; Au AS; Dai SY; Mozafari M; Prakash S J Control Release; 2016 Jan; 221():48-61. PubMed ID: 26646543 [TBL] [Abstract][Full Text] [Related]